CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
." . The aim is to see if this new approach can show early signs of effectiveness in treating participants with a specific type of colon cancer...
Phase 2
Madrid, Spain and 14 other locations
(SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon...
Phase 3
Madrid, Spain and 250 other locations
The purpose of this study is to examine if Nivolumab by itself, or Nivolumab in combination with other anti-cancer drugs, will result in mea ...
Phase 2
Madrid, Spain and 31 other locations
The purpose of this study is to measure tumor response to treatment with ompenaclid (RGX-202) in patients with previously treated RAS mutant...
Phase 2
Madrid, Spain and 27 other locations
and pembrolizumab) given together for the treatment of colorectal cancer that:* is metastatic (spread to other parts of the body);* has the ...
Phase 2
Madrid, Madrid, Comunidad DE, Spain and 111 other locations
dehydrogenase 1 (IDH1) arginine 132 (R132)-mutant advanced solid tumors, including but not limited to cholangiocarcinoma, chondrosarcoma, an...
Phase 1
Madrid, Spain and 32 other locations
This is an open-label, first-in-human study designed to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor ...
Phase 1, Phase 2
Madrid, Spain and 83 other locations
This study is to evaluate the safety, tolerability, and PK profiles of RMC-6291 and RMC-6236 in adults with KRAS G12C-mutated solid tumors....
Phase 1
Madrid, Spain and 27 other locations
inhibitor) monotherapy in adult subjects with advanced solid tumors and to identify the maximum tolerated dose (MTD), and the recommended Ph...
Phase 1
Madrid, Spain and 63 other locations
A phase Ib, open-label platform study of select drug combinations chosen in order to characterize safety and tolerability of each treatment arm teste...
Phase 1
Madrid, Spain and 17 other locations
Clinical trials
Research sites
Resources
Legal